This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend Respiratory Professional Care

If you would like more information on the respiratory system, please refer to the NHS website.

Visit the NHS website?

Co-Located Events

Exhibitor Products

Subpage Hero


Zephyr Valve

Pulmonx Hall: 4 Stand: RD50

The FDA approved the Zephyr® endobrochial valve and granted it breakthrough medical device status in June 2018 because, in its judgment, "it is an innovative technology in offering bronchoscopic lung volume reduction without the need for surgery and associated risks. Compared to the current standard of care, this device offers significant advantages of clinical relevance and therefore its availability is also in the interest of patients."

Among the company's commercially available product range is the Zephyr endobronchial valve. More than 100 scientific articles have been published on the clinical benefits of Zephyr valves, including numerous meta-analyses, review articles, cost-effectiveness analyses, and risk-benefit analyses.